(EMAILWIRE.COM, January 29, 2019 ) The report segments the home healthcare market into the product, service, software, telehealth solutions, and region. Based on the product, the market is segmented into testing, screening, & monitoring products; therapeutic products; and mobility care equipment. The mobility care segment is slated to register the highest CAGR during the forecast period due to the growing geriatric population, ease of use, rising demand for personal independence, and social connectedness. These devices also offer personal security and safety.

The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 239.30 Billion in 2017, at a CAGR of 8.8%. The growth of this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare.

Request for Free Sample Report @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=696

In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as converging trends of the aging population, technological advancement, and rising incidence of chronic diseases.
Asia is expected to grow at the highest CAGR during the forecast period. Factors such as rising geriatric population, increasing adoption of innovative techniques, increasing disposable income, expansion of home healthcare companies in this region, raising awareness of home healthcare, and increasing need for affordable healthcare delivery systems are expected to drive the growth of this market in Asia.

Changing reimbursement policies, limited insurance coverage, and patient safety concerns may limit market growth to a certain extent in the coming years. The home healthcare market is highly competitive with the presence of several small and big players.

Key Players
Prominent players in the home healthcare market include Philips Healthcare (Netherlands), Kindred Healthcare (US), Linde Group (Germany), Almost Family Inc. (US), Abbott Laboratories (US), LHC Group (US), A&D (Japan), Amedisys (US), Fresenius (Germany), Omron (Japan), McKesson (US), BAYADA Home Health Care (US), Kinnser Software, Inc. (US), and Roche (Switzerland).